You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jun 3, 2026
Sale
Calculated transaction value
$346.45K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jun 2, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$540.05
Jun 2, 2026
First close after public filing
$547.69
Jun 4, 2026
30-day return after filing
-0.08%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 641 shares @ $540.48
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000068
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.5M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jun 2, 2026 | $1.39M |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $621.4K |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $1.1M |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $787.08K |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $619.09K |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $1.25M |
| United Therapeutics Corp UTHR Current | Sale | Jun 2, 2026 | $346.45K |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $238.34K |
| United Therapeutics Corp UTHR | Sale | Jun 2, 2026 | $152.11K |
| United Therapeutics Corp UTHR | Exercise | Jun 2, 2026 | $0 |